Novavax, Inc. is an American biotechnology company based in Gaithersburg, Maryland, that develops vaccines to counter serious infectious diseases. Prior to 2020, company scientists developed experimental vaccines for Ebola, influenza, respiratory syncytial virus, and other emerging infectious diseases.
COVID is on the rise again. Those companies' stocks are expected to go up again.